Literature DB >> 4624348

L-DOPA suppression of thyrotropin-releasing hormone response in man.

S W Spaulding, G N Burrow, R Donabedian, M van Woert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4624348     DOI： 10.1210/jcem-35-1-182

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  7 in total

1.  Ultrasensitive TSH assay and anti-parkinsonian treatment with levodopa.

Authors:  B Vergès; M Giroud; G Vaillant; B Verges-Patois; J M Brun; R Putelat
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

Review 2.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

3.  Resolution of dyskinesia and the "on-off" phenomenon in thyrotoxic patients with Parkinson's disease after antithyroid treatment.

Authors:  T H Caradoc-Davies
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-05

4.  Effect of hypoglycaemia, TRH and levodopa on plasma growth hormone, prolactin, thyrotropin and cortisol in Parkinson's disease before and during therapy.

Authors:  H P Vogel; R Ketsche
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

5.  Effects of nomifensine, an inhibitor of endogenous catecholamine re-uptake, in acromegaly, in hyperprolactinaemia, and against stimulated prolactin release in man.

Authors:  M F Scanlon; A Gomez-Pan; B Mora; D B Cook; J H Dewar; A Hildyard; D R Weightman; D C Evered; R Hall
Journal:  Br J Clin Pharmacol       Date:  1977       Impact factor: 4.335

6.  Endocrine aspects of bromocriptine therapy in Parkinsonism.

Authors:  K M Shaw; A J Lees; S Franks; P Daggett; B D Thompson; G M Stern
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

7.  Inhibition of thyrotropin and prolactin secretion by dopamine in man.

Authors:  F Massara; F Camanni; V Vergano; L Belforte; G M Molinatti
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.